期刊文献+

胃癌组织中P53及P21蛋白的表达 被引量:4

THE EXPRESSION OF P53 AND P21 PROTEINS IN TISSUE OF GASTRIC CARCINOMA
在线阅读 下载PDF
导出
摘要 ①目的探讨P53和P21蛋白异常表达在胃癌发生发展中的作用。②方法应用免疫组化技术检测58例胃癌及相应癌旁组织中P53和P21蛋白的表达。③结果胃癌组织P53蛋白阳性表达率为86.21%(50/58),癌旁组织P53蛋白均为阴性表达,胃癌组织P53蛋白阳性表达率明显高于癌旁组织,差异具有极显著性(P=0.000)。胃癌组织P21蛋白阳性表达率为62.07%(36/58),癌旁组织P21蛋白阳性表达率为89.66%(52/58),胃癌组织P21蛋白阳性表达率明显低于癌旁组织,差异有极显著性(2χ=12.5,P<0.01)。胃癌组织中P21与P53蛋白共同阳性表达率为56.9%,但两者无相关性(χ2=1.323,r=0.203,P>0.05)。④结论P53和P21蛋白表达异常与胃癌发生有关。 Objective To investigate the role of abnormal expression of P53 and P21 proteins in the oncogenesis and development of gastric carcinoma. Methods P53 and P21 protein expression were measured by immunohistochemistry in 58 gastric carcinomas and corresponding adjacent tissues. Results P53 immunoreactivity was detected in 50 of 58 gastric carcinomas, but not in the 58 corresponding adjacent normal tissues. The difference was significant between the two groups (P=0.000). P21 immunoreactivity was detected in 36 of 58 gastric carcinomas, and in 52 of 58 corresponding adjacent normal tissues. The difference was also significant (x^2 =12.5, P〈0.01). The co-expression positive rate of P21 and P53 in gastric carcinoma tissues was 56.9%. But there was no significant correlation between P21 and P53 expression (x^2=1.323 ,r=0.203 ,P〉0.05). Conclusion The abnormal expression of P53 and P21 proteins is related with the oncogenesis of gastric carcinoma.
出处 《青岛大学医学院学报》 CAS 2005年第3期223-225,共3页 Acta Academiae Medicinae Qingdao Universitatis
关键词 胃肿瘤 蛋白质P53 蛋白质P21 免疫组织化学 stomach neoplasms protein P53 protein P21 immunohistochemistry
作者简介 时飞(1964-),女,副主任医师。
  • 相关文献

参考文献11

  • 1Leung SY,Chau KY,Yuen ST,et al. P53 overexpression is different in Epstein-Barr virus-associated and Epstein-Barr virus-negative carcinoma[J]. Histopathology,1998,33(4):311.
  • 2Cox LS. Multiple pathways control cell growth and transformation:overlapping and independent activities of P53 and P21 Cipl/WAF1/Sdil[J]. Pathol,1997,183:134.
  • 3Kolar Z,Murmy G,Scott K,et al.Relation of bcl-2 expression to aderogen receptor,P21 WAF1/CIP,and cyclin D1 status in prostate cancer[J].Clin Pathol,2000,53(1):15.
  • 4Blok P,Craanen ME,Dekker W,et al.No evidence for functional inactivation of wild-type P53 protein by mdm2 gene overexpression in gastric carcinogenesis[J].J Pathol,1998,186(1):36.
  • 5Uchino S,Noguchi M,Ochiai A,et al.P53 mutation in gastric cancer:a genetic model for carcinogenesis is common to gastric and colorectal cancer[J].Int J Cancer,1993,54:759.
  • 6Onemura Y,Fushida S,Tsugawa K,et al.Correlation of P53 expression and proliferative activity in gastric cancer[J]. Anal Cell Pathol,1993,5:277.
  • 7Akama Y,Yasui W,Kuniyasu H,et al.No point mutations but codon 31 polymorphism and decreased expression of the P21WAF1 gene in human gastric carcinoma[J]. Md Cell Differen,1996,4(1):187.
  • 8Ogawa M,Maeda K,Onoda N,et al.Immuohistochemical study of P21 expression in gastric carcinoma[J]. Gen To Kagaku Ryoho,1997,24(Suppl 2):292.
  • 9Akama Y,Yasui WI,Kauniyas HS,et al.Genetic status and expression of the cyclin-dependent kinase inhibitions in human gastric carcinoma cell lines[J]. Jpn J Cancer Res,1996,87(8):824.
  • 10Noda H,Maehara Y,Irie K,et al.Growth pattern and expressions of cell cycle regulator protein P53 and P21 WAF2/CIP1 in early gastric carcinoma[J].Cancer,2001,92(7):1828.

同被引文献41

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部